Find My Trial
Woman in her mid-thirties smiling with visible relief, softly lit portrait against slate-to-sky gradient
Real participant · 2025
Trial Match Active

Jennifer Morales, 34 · Houston, TX

Moderate persistent asthma · 11 years on controller therapy

Patient Story
"I was on three medications. Now I'm on one — and it's not even on the market yet."
Jennifer Morales portrait thumbnail

Jennifer Morales

Houston, TX · Matched February 2025

Phase III · Biologic · Matched in 4 minutes

No account required · HIPAA-compliant · 4,200+ patients matched since 2023

Advisory Board

The questions you'd ask
if a doctor was in the room.

Five specialists who vet every trial on Breathe. Click any portrait to hear their answer.

Dr. Patricia Okafor, female pulmonologist in a white coat, smiling confidently

Dr. Patricia Okafor

Pulmonologist

Dr. Marcus Levin, male immunologist with salt-and-pepper hair, professional headshot

Dr. Marcus Levin

Immunologist

Dr. Sunita Krishnamurthy, South Asian female allergist, warm expression, clinical setting

Dr. Sunita Krishnamurthy

Allergist-Immunologist

Dr. James Whitfield, male respiratory physician, fifties, thoughtful expression

Dr. James Whitfield

Respiratory Physician

Dr. Angela Torres, Latina female pediatric pulmonologist, gentle smile, hospital background

Dr. Angela Torres

Pediatric Pulmonologist

"Is it safe?"

Dr. Patricia Okafor, female pulmonologist in a white coat, smiling confidently

Dr. Patricia Okafor

Johns Hopkins Medicine

Every trial on Breathe has cleared Phase I safety reviews. We only list studies that have passed FDA oversight and independent ethics board approval. Your safety is the precondition — not an afterthought.

Board Certified · 18 years pulmonary research

"You're not a guinea pig — you're a partner in the research."

How Matching Works

Three steps.
Four minutes.

We do the eligibility parsing. You just answer three honest questions.

Step 01

Tell us how you breathe today.

Four illustrated breath icons — intermittent, mild persistent, moderate, severe. Tap the one that matches your last 30 days. No medical form. No jargon.

Inter- mittent
Mild
Moderate
Severe
Step 02

How far will you travel?

Enter your zip code. Drag the radius slider — 10 to 250 miles. We surface trials within reach.

10 mi75 mi selected250 mi
Step 03

Book a 15-minute call.

Speak with a trial navigator — not a sales rep. They answer questions, not pitches.

Today 2:00 PM

15 min · Video

Today 4:30 PM

15 min · Video

Tomorrow 10:00 AM

15 min · Video

Tomorrow 1:00 PM

15 min · Video

4,200+

patients matched since 2023

across 38 states · 14 trial sponsors

4 min

average time to first match

vs. 40 hours on ClinicalTrials.gov

94%

of matched patients met eligibility on first try

pre-screened before navigator call

Trial Finder

You're not a guinea pig.
You're a partner.

Three questions. Four minutes. A list of trials that already know you might qualify — before you make a single phone call.

Dr. Marcus Levin, immunologist, reassuring expression

"The last thing you see before you commit is a doctor saying: you're a partner in the research."

Dr. Marcus Levin · Mayo Clinic Immunologist

4,200+

patients matched

127

active trials listed

38

states covered

Step 1 of 3Condition

How does your asthma feel most days?

Choose the description that best matches the last 30 days.

Browse Anonymously

Not ready to book?
Browse first. Decide later.

No account. No commitment. Save your search with an email and we'll alert you when new trials match.

Phase:
Severity:
Type:

Showing 6 trials

Phase IIIBiologicNew
NCT04892341

Dupilumab vs. Tezepelumab in Moderate-Severe Eosinophilic Asthma

Houston, TX · 3 mi
6 visits over 12 months
Ages 18–65 · Sanofi / Regeneron
Enrollment284/400
Check My Eligibility
Phase IIInhaler
NCT04711083

Inhaled CXCR2 Antagonist for Neutrophilic Asthma Exacerbations

Dallas, TX · 18 mi
4 visits over 6 months
Ages 21–55 · AstraZeneca
Enrollment89/150
Check My Eligibility
Phase IIIBiologic
NCT05123456

Pediatric Biologic Safety Study: Benralizumab Ages 6–11

Austin, TX · 24 mi
8 visits over 18 months
Ages 6–11 · AstraZeneca
Enrollment42/120
Check My Eligibility
Phase IIDevice
NCT04988712

Digital Inhaler Adherence Monitoring in Mild Persistent Asthma

San Antonio, TX · 31 mi
2 visits + remote monitoring
Ages 16–70 · Propeller Health
Enrollment167/200
Check My Eligibility
Phase IIIBiologicNew
NCT05234789

Anti-TSLP Monoclonal Antibody for Severe Refractory Asthma

New Orleans, LA · 58 mi
10 visits over 24 months
Ages 18–75 · Amgen
Enrollment198/350
Check My Eligibility
Phase IIOral
NCT04567890

Microbiome Modulation via Probiotic in Exercise-Induced Asthma

Houston, TX · 5 mi
3 visits over 4 months
Ages 18–45 · Vedanta Biosciences
Enrollment54/80
Check My Eligibility

Ready to move forward?

Let us find the trial that was
written for someone like you.

Find My Trial

No account required · HIPAA-compliant